Ep. 34 - How to reform the orphan drug market

This week on the FLATLINING Podcast, Matthew and Ron take on the money-related topics of medical debt and orphan drugs. Who does medical debt hurt more: patients or providers? Is Medicare for All or single payor healthcare the solution to medical debt? Drug companies make billions on orphan drugs, meant for a small number of people with very serious illnesses. Is this ethical? What was the purpose of the Orphan Drug Act? How can the drug market be reformed? Ron and Matthew take on all of these topics on this week’s episode of the FLATLINING Podcast. Happy new year everyone! Join the conversation in our chat! Subscribe to the FLATLINING Podcast on Apple Podcasts, Spotify, the iHeartRadio app, Amazon Music, Google Podcasts, Stitcher, Pandora, and Audible. The FLATLINING Podcast is now available on TuneIn! Articles mentioned in this program: Hundreds of Hospitals Sue Patients or Threaten Their Credit, a KHN Investigation Finds. Does Yours? - Kaiser Health News Life-saving treatments, blockbuster profits - WORLD Magazine Nonprofit healthcare will likely take years to recover, S&P says - Becker’s Hospital Review This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.flatlining.net